Your browser doesn't support javascript.
loading
Carfilzomib Enhances the Suppressive Effect of Ruxolitinib in Myelofibrosis.
Claudiani, Simone; Mason, Clinton C; Milojkovic, Dragana; Bianchi, Andrea; Pellegrini, Cristina; Di Marco, Antinisca; Fiol, Carme R; Robinson, Mark; Ponnusamy, Kanagaraju; Mokretar, Katya; Chowdhury, Avirup; Albert, Michael; Reid, Alistair G; Deininger, Michael W; Naresh, Kikkeri; Apperley, Jane F; Khorashad, Jamshid S.
Afiliación
  • Claudiani S; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
  • Mason CC; Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of Utah, Salt Lake City, UT 84108, USA.
  • Milojkovic D; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
  • Bianchi A; Department of Information Engineering, University of L'Aquila, 67100 L'Aquila, Italy.
  • Pellegrini C; Department of Biotechnological and Applied Clinical Science, University of L'Aquila, 67100 L'Aquila, Italy.
  • Di Marco A; Department of Information Engineering, University of L'Aquila, 67100 L'Aquila, Italy.
  • Fiol CR; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
  • Robinson M; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
  • Ponnusamy K; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
  • Mokretar K; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
  • Chowdhury A; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
  • Albert M; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
  • Reid AG; Molecular Pathology Unit, Liverpool University, Liverpool L7 8XP, UK.
  • Deininger MW; Versiti Blood Research Institute, Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • Naresh K; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
  • Apperley JF; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
  • Khorashad JS; Centre for Haematology, Department of Immunology and Inflammation, Imperial College, London W12 0NN, UK.
Cancers (Basel) ; 13(19)2021 Sep 28.
Article en En | MEDLINE | ID: mdl-34638347
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza